AAO News
The latest clinical breakthroughs, practice management updates, and national advocacy alerts directly from the American Academy of Ophthalmology.
Glaucoma drug meets primary endpoint
Rhopressa showed non-inferiority to timolol in glaucoma patients with a baseline IOP below 25 mm Hg, reports Aerie Pharmaceuticals.
Powered by Börsen-Handelssysteme

West Virginia Academy of Eye Physicians and Surgeons — advancing quality eye care through education, advocacy, and community awareness.
About
Resources
Advocacy

























